MDI Health and VirtualHealth are excited to announce a new partnership. MDI’s technology utilizes AI to reimagine medication management and help leading payors and value-based care providers improve medication treatment, lower costs, and improve clinical outcomes.
“MDI’s solution will be an incredible addition to the HELIOS platform. Its comprehensive analysis and AI automation capabilities significantly reduce the total cost of care for at-risk populations. MDI can enable payers to scale their impact through auto-generation of personalized, high-impact clinical interventions,” said Sue Powers, Chief Growth Officer at VirtualHealth. “We know how important medication management is to our clients, and MDI’s HIPAA-compliant solution will help HELIOS users save on utilization and Rx spend, reduce the risk of drug-related medical events, and help their clinical teams to be more efficient and effective.”
MDI Health’s solution has been shown to help payers more accurately identify at-risk populations, improve STAR ratings, decrease hospitalizations, and prevent adverse drug events.
“Due to the hyper-personalized and comprehensive analysis of our system, we continuously find millions of dollars in savings on top of existing payors’ clinical programs,” said Avishai Ben-Tovim, CEO at MDI Health. “We’ve seen $2,000 in savings per high-risk member annually, along with a remarkable 20% reduction in medications per individual, so we’re excited to partner with HELIOS and help their clients see similar results. We’re excited to have this opportunity to partner with VirtualHealth to bring our solution to enhance the HELIOS platform’s strong clinical capabilities.”